Interferons and cerebral palsy (Q30652944)

25 June 2017

title

Interferons and cerebral palsy (English)

1 reference

25 June 2017

1 reference

Grether JK

1

1 reference

25 June 2017

Nelson KB

series ordinal

2

1 reference

25 June 2017

Dambrosia JM

series ordinal

3

1 reference

25 June 2017

Phillips TM

series ordinal

4

1 reference

25 June 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

The Journal of Pediatrics

25 June 2017

published in

1 reference

25 June 2017

volume

134

1 reference

25 June 2017

issue

3

1 reference

25 June 2017

page(s)

324-332

1 reference

Neurologic sequelae following interferon therapy of juvenile laryngeal papilloma

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Successful treatment of infantile hemangiomas with interferon-alpha-2b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Neonatal cytokines and coagulation factors in children with cerebral palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

The California Cerebral Palsy Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myelocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Persistent neurotoxicity of systemically administered interferon-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Seizures in children during interferon alpha therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Aicardi-Goutières syndrome: an expanding phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Controlling the complement system in inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Complement fragment C3a in plasma of asphyxiated neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Complement and contact activation in term neonates after fetal acidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Complement biosynthesis in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Expression of complement in the brain: role in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Euthyroid sick syndrome: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Cytokine-induced autoimmune disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Interferon-alpha-induced thyroid dysfunction in patients with chronic active hepatitis C: a transient, reversible and self-limited dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

High interferon alpha levels in placenta, maternal, and cord blood suggest a protective effect against intrauterine herpes simplex virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Interferon gamma gene expression in rat central nervous system glial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Cellular responses to interferon-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Interferon-gamma modulates the fibrinolytic response in cultured human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

The effects of interferon-gamma on the central nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Cytokines in inflammatory brain lesions: helpful and harmful

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Neurologic outcome of prematurity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

Prenatal determinants of motor disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970458-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(99)70458-0

1 reference

25 June 2017

1 reference